Overexpression of CARM1 in breast cancer is correlated with poorly characterized clinicopathologic parameters and molecular subtypes

The ectopic expression of BRCA1 is associated with genesis, progression, and prognosis of breast cancer in young patients

(2013) Qingli Zhang et al.   Diagnostic Pathology

Luminal B tumors are the most frequent molecular subtype in breast cancer of North African women: an immunohistochemical profile study from Morocco

(2012) Hinde El Fatemi et al.   Diagnostic Pathology

Association of COMT Val158Met polymorphism and breast cancer risk: an updated meta-analysis

(2012) Xue Qin et al.   Diagnostic Pathology

Pathologic features and molecular phenotype by patient age in a large cohort of young women with breast cancer

(2011) L. C. Collins et al.   BREAST CANCER RESEARCH AND TREATMENT

CARM1 Is an Important Determinant of ER -Dependent Breast Cancer Cell Differentiation and Proliferation in Breast Cancer Cells

(2011) M. Al-Dhaheri et al.   CANCER RESEARCH

Prognostic significance of molecular subtype in T1N0M0 breast cancer: Korean experience

(2011) R.G. Kim et al.   EJSO

Methylation specifies distinct estrogen-induced binding site repertoires of CBP to chromatin

(2011) D. G. Ceschin et al.   GENES & DEVELOPMENT

Targeted therapies for breast cancer

(2011) Michaela J. Higgins et al.   JOURNAL OF CLINICAL INVESTIGATION

Differential CARM1 expression in prostate and colorectal cancers

(2010) Young-Rang Kim et al.   BMC CANCER

CARM1 mediates the ligand-independent and tamoxifen-resistant activation of the estrogen receptor   by cAMP

(2010) S. Carascossa et al.   GENES & DEVELOPMENT

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

(2010) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

The role and regulation of the nuclear receptor co-activator AIB1 in breast cancer

(2009) Tyler Lahusen et al.   BREAST CANCER RESEARCH AND TREATMENT

Enzymatic Activity Is Required for thein VivoFunctions of CARM1

(2009) Daehoon Kim et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Biochemical Control of CARM1 Enzymatic Activity by Phosphorylation

(2009) Qin Feng et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Trastuzumab Plus Anastrozole Versus Anastrozole Alone for the Treatment of Postmenopausal Women With Human Epidermal Growth Factor Receptor 2–Positive, Hormone Receptor–Positive Metastatic Breast Cancer: Results From the Randomized Phase III TAnDEM Study

(2009) Bella Kaufman et al.   JOURNAL OF CLINICAL ONCOLOGY

Impact of Pathological Characteristics on Local Relapse After Breast-Conserving Therapy: A Subgroup Analysis of the EORTC Boost Versus No Boost Trial

(2009) Heather A. Jones et al.   JOURNAL OF CLINICAL ONCOLOGY

Coactivator Function Defines the Active Estrogen Receptor Alpha Cistrome

(2009) M. Lupien et al.   MOLECULAR AND CELLULAR BIOLOGY

Protein Arginine Methylation in Mammals: Who, What, and Why

(2009) Mark T. Bedford et al.   MOLECULAR CELL

The HER-2 Receptor and Breast Cancer: Ten Years of Targeted Anti-HER-2 Therapy and Personalized Medicine

(2009) J. S. Ross et al.   ONCOLOGIST

Overcoming Drug Resistance in Patients with Metastatic Breast Cancer

(2009) Serena T Wong et al.   PHARMACOTHERAPY

CARM1 Is Required in Embryonic Stem Cells to Maintain Pluripotency and Resist Differentiation

(2009) Qiang Wu et al.   STEM CELLS

CARM1 Regulates Estrogen-Stimulated Breast Cancer Growth through Up-regulation of E2F1

(2008) S. Frietze et al.   CANCER RESEARCH